Peanut Allergy Drug Faces Next Test at Key FDA Panel Meeting

(Bloomberg) -- Aimmune Therapeutics Inc.’s winding road to get its first allergy treatment approved by U.S. regulators faces its next turn when a panel of advisers to the Food and Drug Administrati...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.